GlassScriptPhysician profile
Nicholas Stiles
NPI 1871026617
$696.20
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.55 · 2022: $173 · 2023: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $211.59 | 2021-2022 | |
| Mml US, INC. | $151.10 | 2023 | Reactiv8 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.64 | 2023 | Relistor |
| International Rehabilitative Sciences, INC | $49.23 | 2023 | Rs 4i Plus Sequential Stimulator |
| Pfizer INC. | $46.79 | 2023 | |
| Si-Bone, INC. | $34.00 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $34.00 | 2022-2023 | Seglentis |
| Abbvie INC. | $22.89 | 2023 | Qulipta |
| Halozyme INC | $21.82 | 2023 | |
| Antares Pharma, INC. | $21.15 | 2023 | Xyosted, Tlando, Nocdurna |
| Biohaven Pharmaceutical Holding Company LTD. | $17.97 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.67 | 2023 | Austedo |
| Pacira Pharmaceuticals Incorporated | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Stiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.